Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from french patients with cystic fibrosis

被引:32
作者
Brisse, S
Cordevant, C
Vandamme, P
Bidet, P
Loukil, C
Chabanon, G
Lange, M
Bingen, E
机构
[1] Hop Robert Debre, Microbiol Serv, Observ B Cepacia, F-75019 Paris, France
[2] Inst Pasteur, INSERM, Unite Biodiversite Bacteries Pathogens Emergentes, U389, F-75724 Paris, France
[3] Univ Paris 07, Lab Etud Genet Bacterienne Infect Enfant, EA3105, Paris, France
[4] Inst Pasteur, R&D Div, F-59019 Lille, France
[5] Hop Rangueil, Microbiol Serv, Toulouse, France
[6] Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium
关键词
D O I
10.1128/JCM.42.10.4824-4827.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 153 Burkholderia cepacia strains obtained from 153 French patients with cystic fibrosis were identified as Burkholderia multivorans (51.6%) or Burkholderia cenocepacia (45.1%). Eighty-two genotypes were identified using PvuII and EcoRI ribotyping. B. multivorans genotype A (found in 32 French patients) and two other genotypes were also identified among isolates from Austrian, German, Italian, and Canadian patients.
引用
收藏
页码:4824 / 4827
页数:4
相关论文
共 32 条
[1]   Burkholderia cepacia complex infection in Italian patients with cystic fibrosis:: Prevalence, epidemiology, and genomovar status [J].
Agodi, A ;
Mahenthiralingam, E ;
Barchitta, M ;
Gianninò, V ;
Sciacca, A ;
Stefani, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) :2891-2896
[2]   Burkholderia cepacia genomovar III is a common plant-associated bacterium [J].
Balandreau, J ;
Viallard, V ;
Cournoyer, B ;
Coenye, T ;
Laevens, S ;
Vandamme, P .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2001, 67 (02) :982-985
[3]   Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy:: Genomovar status and distribution of traits related to virulence and transmissibility [J].
Bevivino, A ;
Dalmastri, C ;
Tabacchioni, S ;
Chiarini, L ;
Belli, ML ;
Piana, S ;
Materazzo, A ;
Vandamme, P ;
Manno, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :846-851
[4]   USE OF RIBOTYPING IN EPIDEMIOLOGIC SURVEILLANCE OF NOSOCOMIAL OUTBREAKS [J].
BINGEN, EH ;
DENAMUR, E ;
ELION, J .
CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (03) :311-327
[5]   ARBITRARILY PRIMED POLYMERASE CHAIN-REACTION AS A RAPID METHOD TO DIFFERENTIATE CROSSED FROM INDEPENDENT PSEUDOMONAS-CEPACIA INFECTIONS IN CYSTIC-FIBROSIS PATIENTS [J].
BINGEN, EH ;
WEBER, M ;
DERELLE, J ;
BRAHIMI, N ;
LAMBERTZECHOVSKY, NY ;
VIDAILHET, M ;
NAVARRO, J ;
ELION, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (10) :2589-2593
[6]   Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis [J].
Bonacorsi, S ;
Fitoussi, F ;
Lhopital, S ;
Bingen, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :213-217
[7]   Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping [J].
Brisse, S ;
Verduin, CM ;
Milatovic, D ;
Fluit, A ;
Verhoef, J ;
Laevens, S ;
Vandamme, P ;
Tümmler, B ;
Verbrugh, HA ;
van Belkum, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (05) :1876-1884
[8]   Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex [J].
Brisse, S ;
Stefani, S ;
Verhoef, J ;
Van Belkum, A ;
Vandamme, P ;
Goessens, W .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) :1743-1748
[9]   Automated ribotyping of vancomycin-resistant Enterococcus faecium isolates [J].
Brisse, S ;
Fussing, V ;
Ridwan, B ;
Verhoef, J ;
Willems, RJL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :1977-1984
[10]  
BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115